Laserfiche WebLink
appiicaiion ana nas a nign risK or abuse. i nese agencies <br />were met with public and supplement industry pushback, <br />and no action was taken. A salmonella contamination <br />outbreak in 2018 among users increased concerns. <br />However, says , _,_ instructor of <br />psychiatry and behavioral sciences at the Johns Hopkins <br />University School of Medicine, the new survey findings <br />"suggest that kratom doesn't belong in the category of a <br />Schedule I drug, because there seems to be relatively low <br />rate of abuse potential, and there may be medical <br />applications to explore, including as a possible treatment for <br />pain and opioid use disorder." <br />"There has been a bit of fearmongering;" he adds, "because <br />kratom is opioidlike, and because of the toll of our current <br />opioid epidemic" <br />A 2015 study in Thailand that reported that people in Asia <br />have been using kratom successfully to treat opioid <br />addiction for decades renewed interest among researchers <br />in the U.S. <br />For the current survey, Garcia-Romeu says, he and his team <br />enrolled 2,798 people to complete an online survey on their <br />use of kratom. They recruited participants online and <br />through social media, as well as through the AKA. Overall, <br />users were mostly white, educated and middle-aged. Some <br />